An in-depth look to CALIWAY BIOPHARMACEUTICALS CO LTD operating, investing, and financing activities

6919 free cash flow for Q3 24 is -121.78 M TWD. For 2023, 6919 free cash flow was -432.54 M TWD and operating cash flow was -423.94 M TWD.